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Abstract
Background: Endometriosis is a condition that affects women of reproductive age, where the
glandular and/or stromal tissues from the eutopic endometrium implant in ectopic locations. It is
well established that the survival of ectopic implants is due to lower levels of apoptosis, but no
consensus exists as to which pathway/s this is mediated by. The ubiquitin protein shares a similar
sequence homology to an anti-apoptotic protein called BAG-1 and is expressed in the normal
endometrium. Currently, no studies have been conducted to determine ubiquitin expression and
its possible anti-apoptotic effects in endometriosis.
Methods: Archived endometrial tissues from endometriosis patients and women undergoing
laparoscopic diagnosis (controls) from January 2000 to July 2003 at Westmead Hospital were
examined, where 14 cases of endometriosis and 55 controls were included in the study.
Results: Both the ubiquitin protein and apoptosis were expressed in both glandular and stromal
cells throughout the menstrual cycle of the eutopic endometrium, in which ubiquitin exhibited a
cyclic expression, reaching a peak in late proliferative phase. In contrast, ubiquitin was
predominantly expressed in cells of stromal origin in endometriosis, was no longer regulated by a
cyclic pattern and was associated with an aberrant level of cell survival.
Conclusions: For the first time, this study shows that ubiquitin is expressed in endometriotic cells
and may contribute to a reduced sensitivity of ectopic endometrial tissue to apoptosis. These
findings also suggest that stromal cells contribute differentially to the development of ectopic
endometrial tissue.
Background
Endometriosis is a condition that affects 10% of women
of reproductive age [1]. In the condition, endometrial
glands and/or stroma from the eutopic endometrium
lodge and survive at ectopic sites such as the fallopian
tubes, ovaries and peritoneal cavity. The most accepted
theory as to how these cells migrate to ectopic areas is
Sampson's retrograde menstrual transport theory, where
endometrial cells are shed through the fallopian tubes [2].
Published: 25 September 2004
Reproductive Biology and Endocrinology 2004, 2:69 doi:10.1186/1477-7827-2-69
Received: 09 June 2004
Accepted: 25 September 2004
This article is available from: http://www.rbej.com/content/2/1/69
© 2004 Ilad et al; licensee BioMed Central Ltd. 
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Reproductive Biology and Endocrinology 2004, 2:69 http://www.rbej.com/content/2/1/69
Page 2 of 8
(page number not for citation purposes)
However, what is not known is how these foreign cells
continue to survive in their new ectopic location.
Ubiquitin is a 76 amino acid protein [3] that is involved
in the degradation of short lived, regulatory or misfolded
proteins, thus maintaining cellular homeostasis [4]. Ubiq-
uitin tags these proteins to be taken to the proteasome and
in some instances also to the lysosomic machinery to pre-
vent damage to cells. This is the most cited function of
ubiquitin, although ubiquitin also shares a very similar
sequence homology to the B-cell lymphoma athanogene
1 (BAG-1), which has known anti-apoptotic properties.
To our knowledge, the hypothesis that ubiquitin may
mediate anti-apoptosis within the endometrium has
never been examined and consequently has not been
investigated in the area of ectopic endometrial cell sur-
vival in endometriosis [5].
Accumulating evidence suggests that dysregulated apop-
totic machinery in endometriosis has a role in its patho-
genesis, but no consensus exists as to which pathway/s
this is mediated by [6]. Transformed ectopic endometrial
cells are able to survive due to a number of factors, such as
down regulation of soluble Fas concentrations and a lack
of cell-surface Fas expression on T-cells [7].
Therefore, this study was undertaken to determine the
expression of ubiquitin within endometriosis during the
menstrual cycle and to establish whether it is related to a
decrease in the incidence of apoptosis in this tissue, thus
potentially promoting ectopic endometrial cell survival.
Methods
Tissues
Approval to conduct this study was granted by the Human
Research Ethics Committee of the Western Sydney Area
Health Service. Archived formalin fixed, paraffin embed-
ded tissues from 14 women with endometriosis and 55
women undergoing laparoscopy for non-endometrial
pathologies such as leiomyomata and benign ovarian cyst
were studied. Endometriotic implants (n = 20) and
endometrial tissues (n = 59) were obtained from the
women above, respectively. All tissues were observed
from the Department of Pathology at Westmead Hospital
between January 2000 and July 2003. Mean ages for
endometriosis and control groups were 42.5 ± 2.69 and
36.4 ± 1.17 years, respectively. Women with histological
evidence of malignancy, necrosis, active inflammation or
hormonal treatment were excluded from the study. Con-
trol subjects had normal, regular menstrual cycles and
endometrial samples were collected from the proliferative
and secretory phases of the cycle.
Sectioning
Sections (4 µm) of endometriosis and control endome-
trial tissue blocks were cut on a microtome (Microtome,
Stauffenberg, Germany), placed on superfrost slides
(Menzel-Glaser, Braunscheig, Germany) and air-dried at
room temperature for 24 hours.
Localisation of ubiquitin
De-waxing was performed with two changes of histolene
and absolute ethanol through a single change of 95% (v/
v) and 70% (v/v) ethanol and a final change of tap water.
All incubations were of 5 min duration. Following the
suppression of endogenous peroxidase activity for 10 min
with a blocking agent (DAKO Pty Ltd, Botany, Australia)
sections were incubated with normal goat serum for 60
min to prevent non-specific binding. A polyclonal rabbit
anti-ubiquitin primary antibody (DAKO Pty Ltd, Botany,
Australia) prepared at a titre of 1:100 was added for a fur-
ther 60 min at 37°C. Slides were then washed three times
in tris-buffered saline (TBS: 50 mM Tris HCl, 150 mM
NaCl, pH 7.5; 5 min) before the biotinylated goat anti-
rabbit IgG secondary antibody (DAKO Pty Ltd, Botany,
Australia) prepared at 1:200 was applied (30 min). A
horseradish peroxidase avidin biotinylated complex kit
(HRP-ABC) and diaminobenzidine (DAB) were used
according to the manufacturer's instructions (DAKO Pty
Ltd, Botany, Australia) to detect the secondary antibody.
All washes used TBS except after DAB administration,
where water was used. Sections were counterstained with
haematoxylin and eosin (H&E) and cover slips were
attached using a DAKO aqueous based mounting
medium. Negative controls were obtained through the
omission of the primary antibody to ubiquitin (that
showed the absence of specific staining). Ubiquitin has
increased expression in the normal endometrium in both
the late proliferative and late secretory phase. In this
study, late secretory phase tissue was used as a positive
control [8].
Currently, no single assay exists that detects apoptosis
with high specificity and sensitivity [9]. Thus the TUNEL
technique used in this study was used in conjunction with
the classical method of H&E staining (which detects
nuclear shape changes during the early stages of apopto-
sis) as positive strand break detection alone (TUNEL) may
overestimate the true occurrence of cell death within a
given cell population. A presence of DNA strand breaks,
for example, may not correlate with nuclear segmentation
or may be detected during the late lytic stage of apoptosis,
where most cells are no longer viable.
TUNEL labelling
Sections were deparaffinized and rehydrated with histo-
lene and a graded series of alcohols (absolute, 95%, 90%,
80% and 70%) for 5 min each. This was followed by a 20Reproductive Biology and Endocrinology 2004, 2:69 http://www.rbej.com/content/2/1/69
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min incubation of sections with proteinase K [15 µg/ml in
10 mM Tris/HCl, pH 7.5] at room temperature. Sections
were then rinsed twice in phosphate-buffered saline (PBS)
and reacted with 50 µl of the TUNEL reaction mixture
(Roche Diagnostics, Castle Hill, Australia) for 60 min in a
dark, humidified chamber at room temperature. The sec-
tions were then rinsed three times in PBS and incubated
for a further 30 min with 50 µl of the Converter-POD
(Roche Diagnostics, Castle Hill, Australia) followed by 10
min with DAB. This procedure ensures the detection of
TUNEL labelled cells. Finally, sections are counterstained
and mounted as described for ubiquitin staining. For pos-
itive controls, sections were treated with DNAse 1 to
induce DNA strand breaks or peroxidase blocking solu-
tion was excluded. Negative controls were achieved by
omitting terminal deoxynucleotidyl transferase (TdT;
Roche Diagnostics, Castle Hill, Australia).
H&E stains
The Department of Pathology, Westmead Hospital, kindly
provided the H&E slides used for this study. The basis for
this procedure is to identify cells with cell blebbing,
nuclear condensation and cell shrinkage, which are char-
acteristic features of apoptosis.
Scoring of ubiquitin sections
The ubiquitin staining in the normal and endometriotic
tissue was calculated using a semi-quantitative method to
determine the average intensity scores of the protein in
the nucleus of glands and the stroma using an Optimas
Image Analysis program (Silver Spring, USA). Five ran-
domly selected fields were viewed and evaluated with a
grading of 0, 1, 2 or 3 (negative, weak, moderate, strong)
according to a scale created by Watanabe and colleagues
[10].
Scoring of TUNEL sections
TUNEL apoptotic cell numbers were determined by
counting darkly labelled cells in five randomly selected
fields at X400 and expressed as the apoptotic cell mean/
field according to Meresman and colleagues [11].
Scoring of H&E sections
Ten randomly chosen fields at X600 magnification were
used to determine the number of apoptotic stromal and
glandular cells according to a modified grading scale used
by Meresman and colleagues [12]: (-) < 3 apoptotic cells/
field; (+) >3 apoptotic cells/field.
This modified grading system was used to make statistical
analysis more accurate, as there were only a few samples
that exhibited > 8 apoptotic cells/field. Also, apoptotic
cells were identified by their characteristic morphological
features in H&E-stained late secretory endometrial sec-
tions. These included cell shrinkage and chromatin mar-
gination or chromatin condensation with formation of
apoptotic bodies [12].
Apoptotic bodies were identified by the presence of one,
or several of the following features [13,14]:
1) Single round mass of condensed strongly eosinophilic
cytoplasm with a clump of strongly basophilic, homoge-
nous chromatin.
2) Cytoplasm with more than one piece of condensed
chromatin.
3) Condensed chromatin fragments without cytoplasm.
Statistical analysis
All data is expressed as mean ± SEM. Comparisons
between experimental groups were performed using the
independent t-test and Mann-Whitney U test for paramet-
ric and non-parametric analysis, respectively. A P-value
less than 0.05 was considered a significant difference
between groups.
Results
Immunohistochemistry of ubiquitin in the control 
endometrium and endometriotic implants
Analysis of the effect of the menstrual cycle phase on glan-
dular epithelial cell ubiquitin expression showed a greater
level of ubiquitin during the proliferative phase than the
secretory phase in controls (P = 0.032; Figure 1A,
3A,3D,3G,3J, and 3M) in contrast to ectopic glandular
cells of endometriosis tissues where ubiquitin is higher
during the secretory phase (P = 0.022; Figure 1A, 4A and
4B).
Furthermore, the effect of the menstrual cycle phase on
stromal cell ubiquitin expression, showed a similar level
of ubiquitin between the proliferative and secretory phase
of controls (P > 0.05) in contrast to ectopic stromal cells
of endometriosis tissues where ubiquitin is higher during
the secretory phase (P = 0.020; Figure 1B and 4B).
Detection of apoptotic cells in the control endometrium 
and endometriotic implants
A significantly higher level of apoptosis was observed
using H&E in ectopic glandular cells of patients with
endometriosis in comparison to controls in the prolifera-
tive phase (2.79 ± 0.43 vs 1.90 ± 0.15 respectively; P =
0.04; Figure 2A, 3B,3E and 4C) whereas no significant dif-
ference was seen during the secretory phase (1.29 ± 0.23
vs 1.64 ± 0.19 respectively; P > 0.05; Figure 2A, 3H,3K,3N
and 4D).
Similar levels of apoptosis were observed within prolifer-
ative phase ectopic stromal cells of patients withReproductive Biology and Endocrinology 2004, 2:69 http://www.rbej.com/content/2/1/69
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endometriosis and controls using the H&E method (4.57
± 0.85 vs 5.08 ± 0.50 respectively; P > 0.05; Figure 2C,
3B,3E and 4C). In contrast, a considerably lower level of
apoptosis was observed using H&E in secretory phase
ectopic stromal cells of patients with endometriosis than
in controls (2.73 ± 0.63 vs 4.17 ± 0.33 respectively; P =
0.03; Figure 2C, 3H,3K,3N and 4D).
Apoptotic cells are seen using the TUNEL technique (Fig-
ure 3C,3F,3I,3L,3O, 4E and 4F). However no statistically
significant difference in levels of cell death were observed
for both ectopic glands of endometriosis patients and
controls in either the proliferative (1.73 ± 0.88 vs 1.51 ±
0.38 respectively; P > 0.05; Figure 2B, 3C,3F and 4E) or
secretory phase (1.05 ± 0.48 vs 0.70 ± 0.19 respectively; P
> 0.05; Figure 2B. 3I,3L,3O and 4F). Similar levels of
apoptosis were also observed in ectopic stromal cells of
endometriosis patients and controls using the TUNEL
technique in both the proliferative (4.53 ± 0.93 vs 3.59 ±
0.85 respectively; P > 0.05; Figure 2D, 3C,3F and 4E) and
secretory phase (1.83 ± 0.43 vs 2.08 ± 0.52 respectively; P
> 0.05; Figure 2D, 3I,3L,3O and 4F).
Discussion
Ubiquitin is implicated in the removal of short lived, reg-
ulatory or misfolded proteins but is also widely known to
play a part in DNA repair and removal of virus budding
[4]. The expression of ubiquitin during the proliferative
phase of control tissues is likely to be modulated by
increasing oestrogen since there is an increasing oestrogen
level in response to FSH during folliculogenesis. Thus
ubiquitin may play a role in supporting the developing
endometrium should implantation occur, as its maximal
expression correlates to day 14 of the menstrual cycle. In
addition, Bebington and colleagues have previously
shown an increase in ubiquitin levels during the late secre-
tory phase as an indication that the protein may take part
in the differentiation of the endometrium [8].
In this study, apoptosis was found to be present in
endometriotic tissue with varying intensity. A previous
study of endometriosis has also shown this result [15] but
the possible biological relationship of ubiquitin to this
condition has not previously been elucidated.
Our data shows that the expression of ubiquitin is
increased during the secretory phase of the menstrual
cycle in both glands (Figure 1A) and stroma (Figure 1B) in
A. Ubiquitin grades for glandular cells of control endometrium and endometriotic implants during the menstrual cycle Figure 1
A. Ubiquitin grades for glandular cells of control endometrium and endometriotic implants during the men-
strual cycle. Bars represent mean ± SEM; p < 0.05. P = proliferative and S = secretory. B Ubiquitin grades for stromal 
cells of control endometrium and endometriotic implants during the menstrual cycle. Bars represent mean ± 
SEM; p < 0.05. P = proliferative and S = secretory.
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endometriosis tissues compared to controls. In addition,
the level of apoptosis observed within the glands was
greater during the proliferative phase (Figure 2A), in
contrast with a significant decrease in apoptosis in ectopic
stromal cells during the secretory phase (Figure 2C).
This study suggests that increased levels of ubiquitin
within ectopic endometrial cells may allow their contin-
ued survival, through a yet to be established pathway. The
up-regulation of ubiquitin in human endometriotic tissue
may facilitate ectopic endometrial cell survival, particu-
larly allowing those of stromal origin to grow, survive and
evade T-cell mediated disposal. This finding is of particu-
lar interest because ubiquitin has primarily been attrib-
uted to the removal of aberrant proteins but seems, from
our data, to be also associated with cell survival.
This duality in ubiquitin's role may be attributed to the
type of lysine residue linkage that occurs during polyubiq-
uitination. Studies by Deng and colleagues [16] have
shown that if ubiquitin proteins are linked to each other
through lysine 48, the target protein (in this case proteins
on ectopic endometrial cells), will be directed to the pro-
teasome for degradation. However, if the linkage occurs
through lysine 63, the target protein associates with other
proteins, aiding in its survival.
A. Apoptotic grades for glandular cells of control endometrium and endometriotic implants during the menstrual cycle using  H&E Figure 2
A. Apoptotic grades for glandular cells of control endometrium and endometriotic implants during the men-
strual cycle using H&E. Data are expressed as the apoptotic cell mean/field. Bars represent mean ± SEM; *p < 0.05. Men-
strual cycle phases: P = proliferative and S = secretory. B. Apoptotic grades for glandular cells of control endometrium 
and endometriotic implants during the menstrual cycle using TUNEL Data are expressed as the apoptotic cell 
mean/field. Bars represent mean ± SEM; Menstrual cycle phases: P = proliferative and S = secretory. C. Apoptotic grades for 
stromal cells of control endometrium and endometriotic implants during the menstrual cycle using H&E. Data 
are expressed as the apoptotic cell mean/field. Bars represent mean ± SEM; *p < 0.05. Menstrual cycle phases: P = proliferative 
and S = secretory. D. Apoptotic grades for stromal cells of control endometrium and endometriotic implants 
during the menstrual cycle using TUNEL. Data are expressed as the apoptotic cell mean/field. Bars represent mean ± 
SEM; Menstrual cycle phases: P = proliferative and S = secretory.
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Immunohistochemical staining of control endometrium Figure 3
Immunohistochemical staining of control endometrium. Panels A, D,G,J and M are ubiquitin stained sections where 
brown cells are ubiquitin labelled (X400). Panels B, E, H, K and N are H&E stained sections where  are apoptotic cells 
(X600). Panels C, F, I, L and O are TUNEL stained sections where ▼  are TUNEL positive cells.; Menstrual cycle phases: MP = 
mid proliferative; LP = late proliferative; ES = early secretory; MS = mid secretory and LS = late secretory.
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Our data is consistent with the hypothesis that ubiquitin
has a protective effect on ectopic endometrial cells, partic-
ularly those of stromal origin, as shown by the increased
level of ubiquitin with an associated decrease in apoptosis
during the secretory phase. However, a different mecha-
nism may apply to glandular endometriosis, where
despite a greater ubiquitin expression during the secretory
phase, no significant association was found with ectopic
glandular cell survival. This suggests that an insufficient
ubiquitin tagging during the proliferative phase may
cause ectopic glandular cells to undergo apoptosis.
Other factors that may explain ectopic endometrial cell
survival include the down-regulation of apoptotic recep-
tors [15], failure of immune cells to recognise and elimi-
nate ectopic cells [17] and an increase in cytokine levels
and growth factors in the peritoneal fluid of women with
endometriosis [18].
The significant increase in age of patients with endometri-
osis may have an unknown effect on the level of apoptosis
as older women may have increased incidence of endome-
trial cell death due to increased longevity. However, this
age difference is consistent with another study that also
shows a higher age range in women with the condition
[19].
Our results suggest that ubiquitin is important for
endometrial function throughout the menstrual cycle
where it may play an important role in the regeneration of
the endometrium [5]. Also, a loss of ubiquitin regulation
in the ectopic environment may have an important role in
the pathogenesis of endometriosis. In this respect, it is
interesting that ubiquitin has recently been shown to exert
an immunomodulatory effect in other tissues [20][21].
Endometriotic implants may survive at ectopic locations
Immunohistochemical staining of endometriotic implants Figure 4
Immunohistochemical staining of endometriotic implants. Panels A and B are ubiquitin stained sections where brown 
cells are ubiquitin labelled (X400). Panels C and D are H&E stained sections where  are apoptotic cells (X600). Panel E and F 
are TUNEL stained sections where ▼  are TUNEL positive cells. Menstrual cycle phases: P = proliferative and S = secretory.
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due to a combination of factors, including protection
from apoptosis and immune attack.
Conclusions
In conclusion, this study demonstrates for the first time
that ubiquitin is expressed in endometriotic cells.
Furthermore, the up-regulation of ubiquitin expression
may contribute preferentially to the development of these
ectopic endometrial lesions due to their reduced sensitiv-
ity to apoptosis.
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